Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals (NASDAQ:VRTX) revealed 16 unusual trades.
金融巨头对Vertex Pharmicals采取了明显的看涨举动。我们对Vertex Pharmicals（纳斯达克股票代码：VRTX）期权历史的分析显示了16笔不寻常的交易。
Delving into the details, we found 56% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $155,386, and 12 were calls, valued at $721,286.
深入研究细节后，我们发现56％的交易者看涨，而25％的交易者表现出看跌趋势。在我们发现的所有交易中，有4笔是看跌期权，价值为155,386美元，12笔是看涨期权，价值721,286美元。
Projected Price Targets
预计价格目标
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $340.0 to $470.0 for Vertex Pharmaceuticals over the recent three months.
根据交易活动，看来重要投资者的目标是在最近三个月中将Vertex Pharmicals的价格区间从340.0美元扩大到470.0美元。
Volume & Open Interest Development
交易量和未平仓合约的发展
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Vertex Pharmaceuticals's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Vertex Pharmaceuticals's whale trades within a strike price range from $340.0 to $470.0 in the last 30 days.
在交易期权时，查看交易量和未平仓合约是一个强有力的举动。这些数据可以帮助您跟踪Vertex Pharmicals期权在给定行使价下的流动性和利息。下面，我们可以观察过去30天中Vertex Pharmicals所有鲸鱼交易的看涨和看跌期权交易量和未平仓合约的分别变化，其行使价在340.0美元至470.0美元之间。
Vertex Pharmaceuticals Option Activity Analysis: Last 30 Days
Vertex Pharmicals 期权活动分析：过去 30 天
Significant Options Trades Detected:
检测到的重要期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | CALL | TRADE | BULLISH | 06/21/24 | $94.0 | $89.4 | $94.0 | $360.00 | $235.0K | 197 | 25 |
| VRTX | CALL | TRADE | BULLISH | 01/17/25 | $83.5 | $79.0 | $83.5 | $390.00 | $91.8K | 83 | 11 |
| VRTX | CALL | TRADE | BULLISH | 06/21/24 | $30.0 | $28.0 | $30.0 | $425.00 | $51.0K | 0 | 17 |
| VRTX | CALL | TRADE | BULLISH | 01/17/25 | $34.0 | $31.4 | $33.69 | $470.00 | $50.5K | 141 | 16 |
| VRTX | CALL | TRADE | BULLISH | 06/21/24 | $94.5 | $90.2 | $94.5 | $360.00 | $47.2K | 197 | 30 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | 打电话 | 贸易 | 看涨 | 06/21/24 | 94.0 美元 | 89.4 美元 | 94.0 美元 | 360.00 美元 | 235.0 万美元 | 197 | 25 |
| VRTX | 打电话 | 贸易 | 看涨 | 01/17/25 | 83.5 美元 | 79.0 美元 | 83.5 美元 | 390.00 美元 | 91.8 万美元 | 83 | 11 |
| VRTX | 打电话 | 贸易 | 看涨 | 06/21/24 | 30.0 美元 | 28.0 美元 | 30.0 美元 | 425.00 美元 | 51.0 万美元 | 0 | 17 |
| VRTX | 打电话 | 贸易 | 看涨 | 01/17/25 | 34.0 美元 | 31.4 美元 | 33.69 美元 | 470.00 美元 | 50.5 万美元 | 141 | 16 |
| VRTX | 打电话 | 贸易 | 看涨 | 06/21/24 | 94.5 美元 | 90.2 美元 | 94.5 美元 | 360.00 美元 | 47.2 万美元 | 197 | 30 |
About Vertex Pharmaceuticals
关于 Vertex 制药
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Vertex Pharmaceuticals是一家全球生物技术公司，致力于发现和开发用于治疗严重疾病的小分子药物。其主要药物是治疗囊性纤维化的Kalydeco、Orkambi、Symdeko和Trikafta/Kaftrio，其中Vertex疗法仍然是全球的护理标准。Vertex通过Casgevy实现了其产品组合的多元化，Casgevy是一种治疗β地中海贫血和镰状细胞病的基因编辑疗法。此外，Vertex正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及针对APOL1介导的肾脏疾病的小分子抑制剂。Vertex还在研究细胞疗法，为1型糖尿病提供潜在的功能性治疗方法。
Where Is Vertex Pharmaceuticals Standing Right Now?
Vertex Pharmicals 现在处于什么位置？
- With a trading volume of 970,917, the price of VRTX is up by 0.47%, reaching $449.65.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 68 days from now.
- VRTX的价格上涨了0.47％，达到449.65美元，交易量为970,917美元。
- 当前的RSI值表明该股可能已被超买。
- 下一份收益报告定于即日起68天后发布。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比，期权是一种风险更高的资产，但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。